Low risk of hepatitis B virus recurrence after withdrawal of long-term hepatitis B immunoglobulin in patients receiving maintenance nucleos(t)ide analogue therapy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples